AIKON Health Secures OPZUID Subsidy to Revolutionize Heart Failure Care​​

​

AIKON Health B.V., in collaboration with TNO, Unitron Systems B.V., and Datacation B.V., has successfully secured funding from the OPZuid 2021–2027 program. The investment will accelerate product development, testing and clinical validation.